Naya Biosciences, Stock Price on November 5, 2024
| NAYA Stock | 0.94 0.01 1.08% |
Below is the normalized historical share price chart for NAYA Biosciences, extending back to November 11, 2008. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of NAYA Biosciences, stands at 0.94, as last reported on the 29th of November, with the highest price reaching 0.96 and the lowest price hitting 0.85 during the day.
If you're considering investing in NAYA Stock, it is important to understand the factors that can impact its price. NAYA Biosciences, appears to be out of control, given 3 months investment horizon. NAYA Biosciences, has Sharpe Ratio of 0.066, which conveys that the company had a 0.066% return per unit of standard deviation over the last 3 months. By inspecting NAYA Biosciences,'s technical indicators, you can evaluate if the expected return of 0.82% is justified by implied risk. Please exercise NAYA Biosciences,'s mean deviation of 5.16, and Downside Deviation of 5.47 to check out if our risk estimates are consistent with your expectations.
NAYA Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 21st of May 2012 |
NAYA |
Sharpe Ratio = 0.066
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | NAYA | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 12.44 actual daily | 96 96% of assets are less volatile |
Expected Return
| 0.82 actual daily | 16 84% of assets have higher returns |
Risk-Adjusted Return
| 0.07 actual daily | 5 95% of assets perform better |
Based on monthly moving average NAYA Biosciences, is performing at about 5% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of NAYA Biosciences, by adding it to a well-diversified portfolio.
Related Headline
Stepan Headline on 5th of November 2024
Soji Arai To Star In Penthouse Thriller From Director Stepan... by deadline.com
Soji Arai is set to star in Penthouse, an indie thriller from Yakutian director Stepan Burnashev, Deadline can exclusively reveal.
NAYA Biosciences, Valuation on November 5, 2024
It is possible to determine the worth of NAYA Biosciences, on a given historical date. On November 5, 2024 NAYA was worth 0.81 at the beginning of the trading date compared to the closed value of 0.83. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of NAYA Biosciences, stock. Still, in general, we apply an absolute valuation method to find NAYA Biosciences,'s value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of NAYA Biosciences, where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against NAYA Biosciences,'s related companies.
| Open | High | Low | Close | Volume | |
| 0.76 | 0.79 | 0.75 | 0.79 | 160,998 | |
11/05/2024 | 0.81 | 0.84 | 0.79 | 0.83 | 38,281 |
| 0.74 | 0.83 | 0.74 | 0.81 | 56,441 |
| Backtest NAYA Biosciences, | | | NAYA Biosciences, History | | | NAYA Biosciences, Valuation | Previous | Next |
NAYA Biosciences, Trading Date Momentum on November 5, 2024
| On November 06 2024 NAYA Biosciences, was traded for 0.81 at the closing time. The top price for the day was 0.83 and the lowest listed price was 0.74 . The trading volume for the day was 56.4 K. The trading history from November 6, 2024 was a factor to the next trading day price decrease. The trading delta at closing time against the next closing price was 2.41% . The trading delta at closing time against the current closing price is 3.61% . |
About NAYA Biosciences, Stock history
NAYA Biosciences, investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for NAYA is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in NAYA Biosciences, will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing NAYA Biosciences, stock prices may prove useful in developing a viable investing in NAYA Biosciences,
NAYA Biosciences, Stock Technical Analysis
NAYA Biosciences, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
NAYA Biosciences, Period Price Range
Low | November 29, 2024
| High |
0.00 | 0.00 |
NAYA Biosciences, cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
NAYA Biosciences, November 29, 2024 Market Strength
Market strength indicators help investors to evaluate how NAYA Biosciences, stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading NAYA Biosciences, shares will generate the highest return on investment. By undertsting and applying NAYA Biosciences, stock market strength indicators, traders can identify NAYA Biosciences, entry and exit signals to maximize returns
NAYA Biosciences, Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for NAYA Biosciences,'s price direction in advance. Along with the technical and fundamental analysis of NAYA Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of NAYA to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0576 | |||
| Jensen Alpha | 0.4668 | |||
| Total Risk Alpha | (1.08) | |||
| Sortino Ratio | 0.117 | |||
| Treynor Ratio | 0.3022 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for NAYA Stock analysis
When running NAYA Biosciences,'s price analysis, check to measure NAYA Biosciences,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NAYA Biosciences, is operating at the current time. Most of NAYA Biosciences,'s value examination focuses on studying past and present price action to predict the probability of NAYA Biosciences,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NAYA Biosciences,'s price. Additionally, you may evaluate how the addition of NAYA Biosciences, to your portfolios can decrease your overall portfolio volatility.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| CEOs Directory Screen CEOs from public companies around the world |